The Siglec-like Serine-Rich Repeat (SRR) adhesins mediate bacterial attachment to mammalian hosts via sialoglycan receptors. Here, we combine structural, computational, biochemical, and phylogenetic approaches to elucidate the determinants of the sialoglycan-binding spectrum across the family of Siglec-like SRR adhesins. We further identified mutable positions that disproportionately affect sialoglycan selectivity, as demonstrated by increases in binding to alternative ligands of 2-to 3-orders of magnitude. Biologically, these studies highlight how bacteria nimbly modulate the receptor interaction during coevolution of host and pathogen. These studies additionally created binding proteins specific for sialyl-T antigen or 6S-sialyl Lewis X that can recognize glycosylation of human plasma proteins. The engineered binding proteins can facilitate the characterization of normal cellular glycan modifications or may be used as diagnostic tools in disease states with altered glycosylation.
he decoration of proteins with sialoglycans is functionally important in numerous mammalian signaling pathways. However, a wide array of bacterial and viral adhesive proteins exploit these sialoglycans as host receptors during infection. In these cases, sialoglycan selectivity determines whether a pathogen can adhere to a preferred anatomical niche or can infect a particular host (1, 2) .
Sialic acid binding immunoglobulin like lectin (Siglec)-like adhesins are found within the larger family of Serine-rich repeat (SRR) adhesins (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , which form fibril-like protrusions on streptococci and staphylococci (15) . The Siglec-like adhesins (3, 7, (16) (17) (18) (19) (20) (21) (22) (23) always include two adjacent modules: a "Siglec" domain and a "Unique" domain (21) . In oral streptococci, Siglec-like adhesins bind to carbohydrates containing a terminal Siaα2-3Gal (Sia = Neu5Ac or Neu5Gc) (3, 4, 7-9, 16-19, 22) at a YTRY T sequence motif (16, 18, 21, 24) . In humans, Neu5Acα2-3Gal is commonly found at the termini of the complex Olinked sialoglycans that modify the MUC7 salivary mucin (9, 16, 25) or glycoproteins in both blood plasma (17) and on platelets (8, 23) . Binding to α2-3-linked sialoglycans may therefore allow colonization of the oral cavity, or can lead to endovascular infection (4, 21, 22, 26) .
Sequences of the Siglec-like adhesins are quite variable, as are the host sialoglycans to which they bind. For example, GspB from Streptococcus gordonii strain M99 binds with narrow selectivity to the sialyl-T antigen (sTa) trisaccharide (3, 16, 19) (for carbohydrate structures, see Fig. S1 ). In contrast, other SRR adhesins, such as Hsa from S. gordonii strain Challis, bind with high avidity to multiple glycans (3, 16, 19) .
Here, we evaluated sialoglycan binding and selectivity of Siglec-like adhesins using structural, computational, and biochemical approaches. We then used this information to engineer adhesins with altered binding properties and showed that this affected the preferred host receptor. Our findings provide insights into the molecular basis for sialoglycan selectivity by Siglec-like adhesins and suggest a route for developing these adhesins into a broad array of tools to characterize sialoglycan distribution.
Results

Selection of representative adhesins
We began by correlating phylogenetic analysis of sialoglycan-binding Siglec and Unique domains ( Fig. S2) with reported sialoglycan selectivity (3, 16, 17, 19, 20) . This identified that evolutionary relatedness is a moderate, but not strong, predictor of glycan selectivity. In short, most of the adhesins of the first major branch of the tree (blue in Fig. S2 ) bound two or more related tri-or tetrasaccharides, albeit without a clear glycan preference (3, 16, 17, 19, 20) . In contrast, the four characterized adhesins of the second major branch (green in Fig. S2 ) exhibit narrow selectivity for sTa (3, 16, 17, 19, 20) .
From the first branch of the tree (blue in Fig. S2) , we selected the Siglec and Unique domains of Hsa (termed Hsa Siglec+Unique ), and the equivalent domains from Streptococcus sanguinis strain SK678 and Streptococcus mitis strain NCTC10712 for further study. These three adhesins are >80% identical but exhibit different receptor selectivity. Hsa Siglec+Unique binds detectably to a broad range of Siaα2-3Galβ1-3/4HexNAc glycans but not to fucosylated derivatives (16, 19) . In comparison, SK678 Siglec+Unique exhibits narrow selectivity for 3'-sialyl-N-acetyllactosamine (3'sLn) and 6-O-sulfo-sialyl Lewis X (6S-sLe X ), while NCTC10712 Siglec+Unique binds strongly to a range of 3'sLn-related structures (16) . The combination of high sequence identity and distinct binding spectrum suggests that we will be able to pinpoint the origins of sialoglycan selectivity with these comparators.
The second major branch of the evolutionary tree (green in Fig. S2) includes GspB from S. gordonii strain M99 (3, 8, 9, 21, 27) . GspB Siglec+Unique exhibits narrow selectivity for the sTa trisaccharide, as do the other previously-characterized members of this evolutionary branch (3, 16, 17, 19, 20) . In seeking comparators of GspB, we performed binding studies on additional homologs. We identified that the Siglec and Unique domains of the adhesin from S. gordonii strain SK150 (termed SK150 Siglec+Unique ) are 62% identical to the corresponding regions of GspB but exhibit broader carbohydrate selectivity (Fig. S3) . The distinct binding properties make these good comparators for understanding sialoglycan selectivity.
Structures of the Hsa-like and GspB-like adhesins
Using these five comparators, we evaluated how sequence differences affect the structure. As determined by crystallography ( Fig. 1A-1D Table S1 , S2), all five adhesins exhibited similar folds of the individual domains ( Fig. 1A, 1B) . However, the interdomain angle differed between the Hsa-like and GspB-like adhesins in a way that correlates with phylogeny ( Fig. 1C, 1D, S4A) .
Notably, even in closely-related adhesins, the Siglec domain contains conformational differences in three loops of the V-set Ig fold: the CD loop, the EF loop, and the FG loop (Fig. 1C, 1D ). Sequence variation of these adhesins disproportionately maps to these loops ( Fig. S4D) . Taken together, these studies of unliganded adhesins identify features that correlate with phylogeny and reveal regions of disproportionate variation in closely related adhesins.
Sialoglycan binding and conformational selection
We next determined costructures of sTa with Hsa Siglec+Unique ( Fig. 2A) or the Siglec domain of GspB (GspB Siglec ) ( Fig. 2B) . In both costructures, sTa binds in a defined pocket of the Siglec domain ( Fig. 2A, 2B) . This pocket is analogous to the sTa-binding site identified in the SRR adhesin SrpA from S. sanguinis strain SK36 (18, 20) ( Fig. 2C) , which phylogenetically groups with Hsa ( Fig.  S2) . Interactions between sTa and each adhesin involves the YTRY sialic acid-binding motif (Hsa 338-341 or GspB 482-485 ) ( Fig. 2D, Fig. S5) (16) and three inserts of the V-set Ig fold: the CD loop (Hsa 284-296 or GspB 440-453 ), the EF loop (Hsa 330-336 or GspB 475-481 ), and the FG loop (Hsa 352-364 or GspB 499-511 ) ( Fig. 2, Fig. S5 ). These same regions vary disproportionately in both sequence and conformation in the unliganded structures ( Fig. 1, S4D) .
The YTRY motif is located on the F-strand of the V-set Ig fold and contributes to binding the invariant terminal Siaα2-3Gal of the target O-linked sialoglycans (18, 21, 24) . However, the role of the three loops in glycan affinity and selectivity is unknown. We queried whether these loops exhibited inherent flexibility, a property believed to correlate with the ability to evolve binding to new ligands (28) (29) (30) . Temperature factor analysis suggests that these loops have high flexibility in the absence of ligand ( Fig.  S6) . Moreover, these loops exhibit conformational differences between the ligand-bound and ligand-free structures ( Fig. 1, 3) . In the GspB Siglec structure, the helix of the FG loop rotates 10° in response to sTa which results in a maximal displacement of 1.3 Å (Fig. 3A) while in the Hsa Siglec+Unique structure, the EF loop moves 5.9 Å ( Fig. 3B ) and allows the Hsa K335 carbonyl to form hydrogen-bonding interactions to the Neu5Ac C5 nitrogen and C4 hydroxyl.
To explore the conformations available to these loops, we performed MD simulations of unliganded Hsa Siglec+Unique and GspB Siglec+Unique . The loops surrounding the glycan binding pocket exhibited considerably more flexibility than other parts of the protein ( Fig. S7A-D) . Moreover, the ligand-bound conformation is among the predicted conformations sampled in the absence of ligand ( Fig. 3,  S7 ). Of particular note is the main chain carbonyl of Hsa K335 , which forms a hydrogen bond to sTa in the experimental costructure and samples both the bound and unbound states in the apo form ( Fig. 3B, 3C) . These calculations predict that sTa shifts the equilibrium of the EF loop to the position observed in the crystal structure of the bound state ( Fig. 2D, 3B, 3C, S5A) . Together, these analyses support a conformational selection mechanism over an induced fit mechanism, a property that may allow adaptation to changes of the host O-glycan receptors.
To experimentally assess whether conformational selection could contribute to ligand binding, we focused on the broadly selective Hsa Siglec+Unique . We introduced rigidifying prolines or replaced glycines at predicted hinges (Hsa N333P , Hsa G287A/G288P ), both of which are predicted to reduce the flexibility required for conformational selection. As controls, we developed variants that introduced glycines (Hsa L363G , Hsa S253G ) ( Fig. S8A) . Hsa N333P was associated with substantially reduced sialoglycan binding for all ligands tested; Hsa G287A/G288P also exhibited reduced binding, but the effect was less pronounced ( Fig. S8B -S8D) . In contrast, glycine-substituted Hsa L363G and Hsa S253G exhibited binding similar to wild-type ( Fig. S8B -S8D) . These experiments provide support for a conformational selection mechanism.
Sialoglycan binding spectrum
All characterized ligands of the Siglec-like SRR adhesins contain a Siaα2-3Gal disaccharide at the nonreducing terminus (16, 19) . However, the identity of, and linkage to, the adjacent sub-terminal sugar varies. Analysis of the contacts in the costructures of Hsa Siglec+Unique and GspB Siglec with sTa identified that the sub-terminal sugar predominantly contacts the CD loop and the FG loop of the Siglec domain ( Fig. 2, S5) . In contrast, the Neu5Acα2-3Gal interacts with the YTRY motif and residues in the EF loop ( Fig. 2, S5) .
To test how these loops affect sialoglycan selectivity, we engineered chimeras with the backbone of one adhesin and the loops of a closely-related adhesin. In the SK678 Hsaloops and NCTC10712 Hsa-loops chimeras, selectivity became more similar to that of Hsa than the parent adhesin ( Fig. 4 , Table S3 ). This indicates that a major determinant of selectivity in Hsa-like adhesins is the combined contribution of the CD, EF, and FG loops. We next assessed whether one loop dominates this effect using individual substitutions. SK678 Hsa-CD-loop exhibited substantially decreased affinity for 3'sLn and 6S-sLe X , while SK678 Hsa-EF-loop had somewhat increased binding for all of the glycans tested, and SK678 Hsa-FG-loop had moderately decreased binding for 3'sLn and a substantially decreased affinity for 6S-sLe X (Fig.  S9A) . NCTC10712 Hsa-CD-loop and NCTC10712 Hsa-FG-loop exhibited differential changes in binding for the sialoglycan ligands, while NCTC10712 Hsa-EF-loop increased the range of bound ligands, but left binding unchanged for the preferred ligands ( Fig. S9B) .
One interpretation of the chimeragenesis data takes into consideration the position of each loop with respect to the ligand (Fig. 2, S5) . The residues of the EF loop only interact with sialic acid ( Fig. S5 ) and may act in concert with the YTRY motif to support binding of the invariant region of the ligands, i.e. Siaα2-3Gal. Yet substitution of the EF loop of the more promiscuous Hsa into SK678 and NCTC10712 resulted in a somewhat broader binding spectrum ( Fig. S9A, S9B ). We posit that flexibility of the EF loop ( Fig. 3B, 3C , S6, S7) adjusts the orientation of the entire sialoglycan to optimize the interaction between the variant position of the ligand and the CD and FG loops ( Fig. 3 ). If the EF loop controls the ligand orientation, then the CD and FG loops may act in synergy to select the glycan. In particular, the FG loop of Hsa restricts the binding pocket and inhibits accommodation of Fucα1-3GlcNAc, as reflected by the lower binding of sLe X and 6S-sLe X to SK678 Hsa-FG-loop and NCTC10712 Hsa-FG-loop ( Fig. 5D , 5E, S7A, S7B).
We next evaluated chimeras of the GspB-like adhesins. GspB SK150-CD-loop and GspB SK150-FG-loop substantially decreased glycan affinity; as with the Hsa-like adhesins, GspB SK150-EF-loop had little impact ( Fig. S9C) . However, in the GspB SK150-loops chimera, which substituted all three loops, the binding affinity remained low ( Fig. S9C) . One explanation for the uneven success of chimeragenesis is that the Hsa-like chimeras used starting adhesins with more flexible loops that could better adjust to the non-native scaffold. It is also possible that the Hsa-like adhesins benefitted from a better starting match between the sequences. To evaluate these possibilities, we engineered GspB-SK150 "mini-chimeras" swapping only residues that directly contact the ligand (Fig. S5) . The GspB L442Y/Y443N mini-chimera had increased binding to 3'sLn and sLe c and was overall more similar in selectivity to SK150 than to GspB ( Fig. S3 , S10A, S10B); the converse mini-chimera of SK150 still exhibited reduced binding (Fig. S10C) . The incomplete success of the mini-chimeras suggests that both the sequence match of the starting adhesins and the limited loop flexibility impacted the ability to alter selectivity via chimeragenesis.
Engineered adhesins with altered selectivity
If we are correct that selectivity is largely conferred by the CD and FG loops, we should be able to engineer the binding spectrum through mutation of these loops. We selected the Hsa-like adhesins, where chimeragenesis had greater success ( Fig. 4) , possibly as a result of increased loop flexibility. Hsa E286 (in the CD loop) and Hsa D356 (in the FG loop) each directly contact the GalNAc of sTa ( Fig.  2D ). In these positions and the equivalent positions of SK678 and NCTC10712, we substituted residues predicted to alter hydrogen-bonding characteristics.
As measured by ELISA, our engineered adhesins exhibited altered binding spectra ( Table S3 , Fig. 5, Fig.  S11 ). The most striking results were for variants of the CD loop of NCTC10712 Siglec+Unique and SK678 Siglec+Unique , which become highly selective for 6S-sLe X via a substantial increase in binding for this sulfated tetrasaccharide and a decrease in binding to other glycans ( Fig. 5A, 5B) . Variants of the FG loop lost binding to fucosylated ligands but had little increase in binding to alternative ligands ( Fig. 5C,  5D ). As a result, the NCTC10712 Q345D variant became more selective for 3'sLn while the SK678 Q371D variant exhibited low binding to all tested ligands. The observed loss of binding to the fucose-containing sLe X and 6S-sLe X by FG loop variants is consistent with the chimeragenesis showing that the FG loop is particularly important for accommodation of fucosylated sialoglycans ( Fig. S9A,  S9B) .
We also found that Hsa E286R , Hsa D356R , and Hsa D356Q (Fig. S11 ) increased binding to 3'sLn, sLe C , sLe X , and 6S-sLe X as compared to wild-type ( Fig. 4A) , but showed different degrees of discrimination between 3'sLn, sLe C , and sTa. Hsa E286R showed similar binding to all ligands tested and thus is even more broadly selective than wildtype ( Fig. S11A) . In contrast, Hsa D356R and Hsa D356Q each had an increase in 3'sLn, sLe X , and 6S-sLe X binding, but a decrease in sTa binding. Or in other words, these variants bind to a broad range of ligands with a distinct ligand preference from wild-type via a gain-of-function mechanism.
Engineered adhesins show differential recognition of human plasma glycoproteins
We used these engineered adhesins to assess glycosylation of plasma proteins. Our prior studies identified that Hsa Siglec+Unique preferentially binds proteoglycan 4 (460 kD) in human plasma while NCTC10712 Siglec+Unique binds GPIbα (150 kD). These adhesins also bind different glycoforms of the C1-esterase inhibitor (100 kD) (17) . Here, Far Western analysis showed that the NCTC10712 Hsa-loops and SK678 Hsa-loops chimeras recognized proteoglycan 4 rather than the preferred receptors for wild-type SK678 Siglec+Unique and NCTC10712 Siglec+Unique (Fig. 6A) . We also found that the 6S-sLe X -selective SK678 E302R variant binds both GPIbα and the C1-esterase inhibitor (Fig. 6B) , a binding pattern similar to that of wild-type NCTC10712 Siglec+Unique (Fig. 6A) . This latter finding suggests that 6S-sLe X is present on both GPIbα and C1-esterase inhibitor. It also identifies that SK678 E302R will be useful as a probe for detecting this modification.
Discussion
Individual Siglec-like adhesins recognize sialoglycans with as few as three and possibly more than six linked sugars (16, 17, 19, 20) . Many of these adhesins bind to a preferred ligand with narrow selectivity, and many, like Hsa, bind strongly to multiple ligands (16, 17, 19, 20) . Our results suggest that for the Siglec-like adhesins that recognize trisaccharides, the binding pockets contain two distinct recognition regions. The first region interacts with the sialic acid-containing non-reducing terminus of the sialoglycan, i.e. Siaα2-3Gal (18, 20) . This region is formed from both the YTRY motif on the F-strand (16, 18, 21, 24) and the EF loop (Fig. 2) . The second region selects for the reducing end sugar and is tuned by the CD and FG loops of the V-set Ig fold ( Fig. 4, 5 , S5-S11). One advantage of this architecture is that the likely flexible trisaccharides can productively interact with the binding pocket via multiple approaches, i.e. binding the sialic acid first or by binding the reducing terminus of the glycan first. The concept of a binding site with multiple independent recognition regions can be extrapolated to adhesins that recognize larger sialoglycans. For example, the Siglec-like adhesin SrpA may biologically recognize a hexasaccharide (17) but can bind to partial ligands, albeit with low affinity (16, 18, 20) ( Fig. 2C) .
Mutagenesis (Fig. S8) , chimeragenesis ( Fig. 4, S9 , S10), and computer simulations ( Fig. 3, S7 ) all suggest that flexibility of these loops controls the breadth of the binding spectrum via a conformational selection mechanism. Binding promiscuity correlates with the identity of the EF loop ( Fig. S9) , which suggests a mechanism where the EF loop adjusts ligand orientation.
The variable region of the ligand can then approach the CD and FG selectivity loops at different angles in order to optimize interactions with the myriad of positions of hydrogen-bonding donors and acceptors that decorate the diverse glycans recognized. If the ligand binds to the CD and FG loops first, the order of events would be reversed, but the mechanism unchanged.
Chimeragenesis and mutagenesis also indicate that the CD and FG loops are particularly important in determining the preferred ligand ( Fig. 4, 5 , S9 -S11). The use of loops to control selectivity has previously been observed in other sialoglycan-binding systems. For example, the mammalian Siglec proteins are built upon a V-set Ig-fold but are not detectably related in sequence to the SRR adhesins (20, 21, 31, 32) . In Siglec-7, the CC' loop (33) controls sialoglycan selectivity. From an evolutionary standpoint, having a mutable loop control selectivity makes particular sense for oral bacteria because it allows facile alteration of ligand preference in response to a changing environment. Indeed, mutation of loops is unlikely to impact protein stability.
The more promiscuous Hsa-like adhesins appeared to be particularly amenable to engineering ( Fig. 4, 5 , S11) and mutants exhibited binding increases of 2-to 3-orders of magnitude for non-native ligands. These increases exceed those reported for dedicated engineering studies (34-42), where the maximum enhancement in binding to a non-native glycan is ~20-fold (34-39) but selectivity is often achieved via a decrease in affinity to non-desired ligands in a promiscuous starting lectin (40-42). One intriguing interpretation of the unusually facile engineering of these Siglec-like adhesins is that their biological role necessitates adjusting to changes in host environment. An easily mutable adhesin may confer a survival advantage by allowing a bacterial strain to adapt to changes in the glycan modifications on salivary MUC7, adapt to binding to distinct receptors in a new anatomical location, or even to adapt to a new host. One impact of adaptation to different preferred receptors could be the ability of these bacteria to convert from commensals to pathogens (26) .
An exciting outcome is our engineering of adhesins selective for sTa ( Fig. 4E ) and 6S-sLe X (Fig. 5A, 5B ) on human proteins ( Fig. 6) . Adhesins with novel sialoglycan selectivity have multiple potential applications. The inherent challenges associated with characterizing Oglycans leave many biological questions arising from knowledge of sialoglycan distribution under-addressed. One strategy for mapping the glycome has been to repurpose naturally-occurring glycan-binding proteins as probes (43). Engineered probes could expand the range of detectable glycans. A second application is in detecting altered glycosylation in disease. Overexpression of sialoglycans is a biomarker for many types of cancers and commonly associated with poor prognosis (44-49). Robust antibodies to many sialoglycans, in particular sialyl-Thompson-nouvelle antigen (sTn) have proven a challenge to develop (50). One could envision highly-selective lectins being used for detection of sialoglycans via lectinbased microarrays (43) or ELISAs. These may also be used in histological mapping or affinity purification of specific protein glycoforms. Additional work could develop probes selective for other Siaα2-3Gal-linked sialoglycans or for sialoglycans with other linkages and is a future goal.
Methods
Detailed procedures for protein expression, purification, crystallization, structure determination, computational analyses, and binding assays are described in the SI.
Accession numbers
Atomic coordinates and structure factors have been deposited into the RCSB Protein Data Bank and raw data have been deposited into SBGrid with accession codes listed in Tables S1 and S2. . 5A, 5B) , the GST-SK678 E302R and GST-NCTC10712 E285R variants exhibit increased binding to 6S-sLe X , and reduced binding to 3'sLn and sLe X . Conversely, both the GST-SK678 Q371D and GST-NCTC10712 Q345D variants have substantially reduced binding to the fucosylated ligands sLe X and 6S-sLe X . Measurements were performed using 500 nM of immobilized GSTadhesin and the indicated concentrations of each ligand, and are shown as the mean±SD (n = 2). 
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Materials and Methods
Sequence analysis
Sequences of the tandem Siglec and Unique domains were resected from select adhesins and were aligned using the MUSCLE (1) subroutine in Geneious Pro 11.1.4 (2) . The JTT-G model of evolution was selected using the ProtTest server (3), and the phylogenetic tree was built using the MrBayes (4) subroutine in Geneious Pro 11.1.4 (2) . A distantly-related adhesin from S. mitis strain SF100 (5) was used to root the tree.
Cloning, expression, and purification for crystallization
DNA encoding the adjacent Siglec and Unique domains of GspB, SK150, NCTC10712, or SK678 or the Siglec domain of GspB were cloned into the pBG101 vector (Vanderbilt University), which encodes an N-terminal His 6 -GST tag that is cleavable using 3C protease. Hsa Siglec+Unique was cloned into the pSV278 vector (Vanderbilt University), which encodes a His 6 -maltose binding protein (MBP) tag at the N-terminus followed by a thrombin cleavage site. Proteins were expressed in E. coli BL21 (DE3) in Terrific Broth medium (for GspB proteins and Hsa Siglec+Unique ) or LB (for SK150 Siglec+Unique , NCTC Siglec+Unique and SK678 Siglec+Unique ) with 50 µg/ml kanamycin at 37°C. When the OD 600 reached 0.6-1.4, expression was induced with 0.5-1 mM IPTG at 24°C for 3-7 hrs. Cells were harvested by centrifugation at 5,000 × g for 15 min, optionally washed with 0.1 M Tris-HCl, pH 7.5, and stored at -20 °C before purification. Frozen cells were resuspended in homogenization buffer (20-50 mM Tris-HCl, pH 7.5, 150-200 mM NaCl, 1mM EDTA, 1 mM PMSF, 2 µg/ml Leupeptin, 2 µg/ml Pepstatin) then disrupted by sonication. Lysate was clarified by centrifugation at 38500 × g for 35-60 min and passed through a 0.45 µm filter. Purification was performed at 4 °C. His 6 -GspB-fusion proteins were purified using a Glutathione Sepharose 4B column and were eluted with 30 mM GSH in 50 mM Tris-HCl, pH 8.0. His 6 -SK150 Siglec+Unique /NCTC10712 Siglec+Unique /SK678 Siglec+Unique proteins were purified using Ni 2+ affinity chromatography and eluted with 20 mM Tris-HCl, 150 mM NaCl, 250 mM imidazole, pH 7.6. His 6 -MBP-Hsa Siglec+Unique was purified with an MBP-Trap column and eluted in 10 mM maltose. Eluted proteins were concentrated in a 10kD MW cut-off concentrator and exchanged into either PreScission cleavage buffer (GspB Sigelc , GspB Siglec+Unique , SK150 Siglec+Unique , NCTC10712 Siglec+Unique , or SK678 Siglec+Unique ; 50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1mM DTT) or thrombin cleavage buffer (Hsa Siglec+Unique ; 20 mM Tris-HCl pH 7.5 and 200 mM NaCl). Affinity tags were cleaved with 1 U of appropriate protease (thrombin or 3C) per mg of protein overnight at 4 °C. For the SK150 Siglec+Unique , NCTC10712 Siglec+Unique , and SK678 Siglec+Unique , the affinity tag has a similar molecular weight as the target protein; in these cases, the cleaved sample was passed through a Ni-column to remove the His 6 -GST tag. For GspB domains, adhesin was separated from the affinity tag by passing the cleavage reaction over the second Glutathione Sepharose 4B column in PreScission Buffer. Protein aggregates were removed from GspB domains using a Superose-12 column in 50 mM Tris-HCl pH 7.6 and 150 mM NaCl. For the remaining proteins, aggregates were removed using a Superdex 200 increase 10/30 GL column equilibrated in 20 mM Tris-HCl pH 7.6 (NCTC Siglec+Unique , SK150 Siglec+Unique , SK678 Siglec+Unique ) or in 20 mM Tris-HCl pH 7.5 and 200 mM NaCl (Hsa BR ). After purification, all proteins were >95% pure as assessed by SDS-PAGE and were stored at -80 °C.
Crystallization, data collection, and structure determination All crystallization reactions were performed at room temperature (~23 °C). Unless otherwise noted, diffraction data were collected at -180 °C, processed using HKL200 (6) , and structures were determined by molecular replacement using the Phaser (7) subroutine of Phenix (8) and the search model indicated. Riding hydrogens were included at resolutions better than 1.4 Å. X-ray sources and data collection statistics are found in Supporting Tables 1 & 2 .
GspB-GspB domains were crystallized by the sitting drop vapor diffusion method by equilibrating 1 µL protein and 1 µL reservoir solution over 50 µL of a reservoir solution. Purified GspB Siglec+Unique was concentrated to 9 mg/ml in 20 mM Tris-HCl, pH 7.6 and crystallized using a reservoir containing 0.2 M (NH₄)₂SO₄, 25% polyethylene glycol (PEG) 3350. Crystals were flash cooled by plunging into liquid nitrogen without the addition of cryo protectant. Purified GspB Siglec was concentrated to 22.8 mg/ml in 20 mM Tris-HCl, pH 7.2. Crystals in space group P2 1 2 1 2 were grown with a reservoir solution containing 0.2 M MgCl₂, 0.1 M Tris-HCl, pH 8.5, 30% w/v PEG 4000; crystals in space group R32 were grown with a reservoir containing 4.0 M HCOONa. GspB Siglec was cocrystallized with sTa using reservoir conditions associated with the P2 1 2 1 2 space group and 1 µL of protein-ligand complex (20.5 mg/ml GspB Siglec , 10 mM sTa, 18 mM Tris-HCl, pH 7.2). Structures were determined using the appropriate domain(s) of GspB (PDB entry 3QC5 (9)) resected from the three-domain structure.
SK150--Purified SK150 Siglec+Unique was concentrated to 3.5 mg/ml in 20 mM Tris-HCl, pH 7.6. Crystals were grown by the hanging drop vapor diffusion method by mixing 1 µL protein and 1 µL reservoir solution (0.2 M ammonium sulfate, 25% PEG 4000, 15% ethanol, and 0.1M Bis-tris, pH 7.0) and equilibrating over the reservoir solution. Diffraction data were collected at room temperature (~23 °C) and were processed using the PROTEUM suite. The structure was determined using the Siglec and Unique domains of GspB (PDB entry 3QC5 (9)) as the search model.
Hsa-Crystals of Hsa Siglec+Unique (21.6 mg/ml in 20 mM Tris-HCl, pH 7.2) grew by sitting drop vapor diffusion by equilibrating 1 µL protein and 2 µL reservoir solution over 50 µL of reservoir solution (0.1 M Succinate/Phosphate/Glycine pH 10.0 and 25% PEG 3350). Co-crystals of Hsa Siglec+Unique with sTa were prepared by soaking fully formed crystals in reservoir solution supplemented with 5 mM sTa for 20 hr. Crystals did not require cryoprotection beyond the reservoir solution. The structure of unliganded Hsa BR was determined using S. sanguinis SrpA Siglec+Unique (PDB entry 5EQ2 (10)) as the search model. The structure of sTa-bound Hsa BR was determined by rigid body refinement of unliganded Hsa Siglec+Unique in Phenix (8) .
NCTC10712-Crystals of NCTC10712 Siglec+Unique (3.5 mg/ml in 20 mM Tris-HCl pH 7.5) grew via the hanging drop vapor diffusion method using reservoir containing 0.1 M Tris-HCl pH 7.5 and 32% w/v PEG 4000. Crystal quality was improved by microseeding (Hampton Seed Bead kit) using 0.3 µL of seed, 1.2 µL protein (3.5 mg/ml), and 1.5 µL modified reservoir solution (0.1 M Tris-HCl pH 7.5 and 28% w/v PEG 4000). Crystals were cryoprotected in using a solution containing 50% of the reservoir and 50% glycerol, then cryocooled by plunging in liquid nitrogen. Data were processed using XDS (11) . The structure was determined Hsa Siglec+Unique as the search model. SK678-Crystals of SK678 Siglec+Unique (7 mg/ml in 20 mM Tris-HCl pH 7.6) were grown via the hanging drop vapor diffusion method by equilibrating 1 µL of SK678 Siglec+Unique and 1 µL reservoir solution over the reservoir solution (0.1M Bicine pH 7.6 and 25% PEG 6,000, 0.005M hexamine cobalt(II) chloride). Crystals were cryoprotected in artificial reservoir solution containing 15% glycerol, and 15% ethylene glycol, then cryo cooled by plunging into liquid nitrogen. Diffraction data were processed using XDS (11) . The structure was determined using NCTC10712 BR as the search model.
Crystallographic refinement, and analysis
All models were improved with iterative rounds of model building in Coot (12) and refinement in Phenix (8) . In all structures of GspB subdomains, the unliganded structure of Hsa BR , and the structure of NCTC BR, electron density for hydrogens was observed in later rounds of refinement and riding hydrogens were included in the final model, which reduced the R free by over 1% in each case. Bound cations were assigned as either Na + , Mg 2+ , or Ca 2+ depending upon the abundance of these ions in either the purification or the crystallization conditions, and the previous observation that cations bound to this site are readily exchanged with cations in the buffer (9) . The final models are associated with the statistics listed in Supporting Tables 1 and 2 . When Ramachandran outliers are associated with the models, these are unambiguously defined by clear electron density. For sTa-bound Hsa Siglec+Unique and GspB Siglec , the crystals were isomorphous with unliganded crystals. Accordingly, R free reflections were selected as identical. In both cases, unambiguous electron density for all three sugars of sTa was apparent in the initial maps. Ligand occupancies were held at 1.0 during refinement.
Sialoglycan binding assays DNA encoding wild-type and variant adhesins were cloned into pGEX-3X. Chimeras were designed using an overlay of the coordinates from each adhesin crystal structure. DNA encoding adhesin chimeras were cloned into pGEX-3X. SK678-Hsa chimeras had the Siglec and Unique domains of SK678 and the loops from Hsa. GspB-SK150 chimeras had the Siglec and Unique domains of GspB with selectivity loops of SK150. The pGEX vectors encode an N-terminal glutathione S-transferase (GST) affinity tag, which was used for purification. Individual GST-Siglec+Unique fusions were expressed and purified using glutathione-sepharose, and the binding of biotinylated glycans to immobilized GST-binding regions was performed as described previously (5) .
Far Western and lectin blotting of human plasma proteins
Far-western blotting of human plasma proteins using the indicated GST-binding regions (15 nM) as probes was performed as described (13) .
Interdomain angle calculations
The torsion angle between Siglec and Unique domains for each system (GspB, SK150, Hsa, SK678, NCTC10712, SrpA) were defined as the angle between the planes formed between center of mass (COM) of Siglec and Residue 1 (R1) and COM of Unique and Residue 2 (R2). The two residues (R1 & R2) were chosen based on crystal structure alignment and are listed in Table S4 . Missing residues of SK150 Siglec+Unique were modeled using GspB Siglec+Unique as a template (PDB entry 3QC5, (9) ).
Molecular dynamics (MD) simulations and analyses
For MD simulations, each system (GspB or Hsa) was solvated in a 10 Å octahedral box of TIP3P (14) water. The Amber16 ff14SB (15) force field was used for the protein. In the first step of the MD simulation, the backbone and side chains of the protein was restrained using 500 kcal mol -1 Å -2 harmonic potentials while the system was energy minimized for 500 steps of steepest descent (16) . This step was followed by 500 steps with the conjugate gradient method (17) . In a second minimization step, restraints on the protein were removed and 1000 steps of steepest descent minimization were performed followed by 1500 steps of conjugate gradient. The system was then subjected to MD and heated to 300 K with the backbone and side chains of the protein restrained using 10 kcal mol -1 Å -2 harmonic potentials for 1000 steps. The restraints were released and 1000 MD steps were performed. The SHAKE (18) algorithm was used to constrain all bonds involving hydrogen in the simulations. MD runs (200 ns) were performed at 300 K in the NPT ensemble and a 2 fs time step. The probability distribution analyses and RMSF calculations were performed on 200 ns of 3 independent runs for each system. All analyses were performed using the cpptraj and pytraj (19) python modules of AMBER16. The main chain of Hsa Siglec+Unique displays two alternative conformations between residues 378-384 that is accompanied by a cis-trans isomerization of the non-proline peptide bond between Hsa E381 and Hsa S382 and results in disallowed bond angles for Hsa S383 . In other isoforms of Hsa, the equivalent residue is a proline. Current technologies do not allow main chain alternative conformations to be refined within the same model. One position is modeled in the unliganded Hsa Siglec+Unique structure and one conformation is modeled in the sTa-bound Hsa Siglec+Unique structure; however, electron density for both conformations is clearly visible in both structures.
*The Ramachandran angles identified as outliers (Hsa S253 , Hsa L363 , NCTC10712 S253 , NCTC10712 L361 ) are equivalent in the homologs and are associated with clear electron density. Characterized Hsa-like adhesins (blue) bind to two or more of the indicated sialoglycans; the four characterized GspB-like adhesins (green) have narrow selectivity for sialyl-T antigen. The tree is rooted using the distantly-related S. mitis SF100 adhesin (magenta). Adhesins investigated here are highlighted with a star, and figure panels comparing properties of these adhesins follow this coloring. The structure and ligand binding properties of SrpA, highlighted with a circle, have previously been reported (10, 20) , and SrpA is used as a comparator in this report. Figure S3 . Figure S3 . Binding of select trisaccharides to GST-SK150 Siglec+Unique . GST-SK150 Siglec+Unique (500 nM) was immobilized in 96-well plates, and biotinylated sialoglycan ligands were added at the indicated concentrations. Binding is reported as the mean ± standard deviation, with n = 3. (10)). Residues of each respective adhesin within hydrogenbonding distance of sTa are labeled. Color scheme follows that of Fig. 3 with the CD loop in green, the EF loop in blue, and the FG loop in yellow. Figure S6 . Figure S6 . Temperature factor analysis of adhesins. For each graph, the residue number is on the x-axis, and the crystallographic temperature factor (B-factor) is on the y-axis. Coloring is by relative B-factor. Regions with the lowest B-factors are predicted to have the lowest mobility (dark blue); regions with the highest B-factors are predicted to have the highest mobility (red). Binding of biotin-glycans (2 µg/ml) to GST-NCTC107128 Siglec+Unique containing loops CD, EF, or FG of Hsa, substituted individually. Values correspond to the mean ± standard deviation, with n = 2 (wt) or n = 3 (variants). C. Binding of biotin-glycans (1 µg/ml) to GST-GspB Siglec+Unique containing loops CD, EF, or FG of SK150 substituted either individually or together. Values correspond to the mean ± standard deviation, with n = 3.
Figure S10.
Figure S10. Mini-chimeragenesis of the GspB and SK150 adhesins. Dose-response curves of biotin-glycan binding to immobilized binding regions (500 nM). A. Wild-type GST-GspB Siglec+Unique shows a binding preference for sTa. B. Mini-chimeragenesis with the SK150 adhesin was accomplished with the GST-GspB L442Y/Y443N double mutant. The mini-chimera becomes more broadly selective by increasing the affinity for 3'sLn and sLe C . As a result, it exhibits binding selectivity more similar to wild-type GST-SK150 Siglec+Unique (see Fig. S1 ). C. The converse mini-chimeragenesis of SK150 Siglec+Unique exhibited reduced binding for sialoglycan ligands that bind most avidly to both wild-type GspB Siglec+Unique and SK150 Siglec+Unique . 
